Poll: Biopharma Focuses On Profits, Not Patients
This article was originally published in Scrip
Executive Summary
The results of another poll have shown Americans are fed up with the high prices of prescription drugs in the US – with 72% calling the costs of their medicines "unreasonable" – and want certain actions to be taken to rein in what biopharmaceutical makers charge.